Triazines as Versatile Scaffolds in Drug Discovery: A Comprehensive Review on Recent Advances and Emerging Therapeutic Applications

Abstract:

Triazine is a heterocyclic aromatic ring that is divided into three isomers by nitrogen atom positions. 2-Aza-2-desamino-5,8-dideazafolic acid and 2-azaadenosine are 1,2,3-triazine derivatives, whereas azaribine, tirapazamine, lamotrigine, and 6-azacytosine are 1,2,4-triazine derivatives. Natural antibiotics like fervenulin, reumycin, and toxoflavin have a triazine ring structure. Ammeline, aceto-guanide, acetoguanamine, cyanuric acid, and melamine all include 1,3,5-triazine isomer or s-triazine as a lead structure. Hexamethylmelamine (altretamine), atrazine, cycloguanil, and almitrine are examples of s-triazine-containing medications. Triazines are important in pharmaceutical chemistry because they exhibit a wide range of pharmacological actions, making them valuable for drug design and development. Some triazine analogs have recently been tested in clinical trials, which might lead to more powerful medications and have fewer adverse effects than currently available pharmaceuticals. This article discusses the biological significance and synthesis of several triazine derivatives derived from heterocyclic and Triazine-containing medicines.